- Home
- » Tags
- » Paritaprevir
Top View
- VIEKIRA PAK Safely and Effectively
- GLASS Methodology for Surveillance of National Antimicrobial Consumption
- Treatment-Drugs
- Dasabuvir, Ombitasvir, Paritaprevir, Ritonavir (Viekira XR, Viekira Pak) Reference Number: PA.CP.PHAR.278 Effective Date: 01/18 Last Review Date: 09/17 Revision Log
- Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-Cov-2 in Vitro
- Elbasvir/Grazoprevir (Zepatier) Reference Number: CP.PCH.16 Effective Date: 01.01.20 Last Review Date: 02.20 Line of Business: Commercial, HIM Revision Log
- Viekirax-INN-Ombitasvir, Paritaprevir, Ritonavir;
- ABT-450/R/ABT-267, ABT-333 M14-252 Clinical Study Report R&D/15/1312
- Clinical Policy: Dasabuvir, Ombitasvir, Paritaprevir, Ritonavir (Viekira Pak)
- Ribavirin Dose Management in HCV Patients Receiving Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin J
- Paritaprevir PK Fact Sheet Produced March 2016 Page 1 of 2 for Personal Use Only
- Genotype 1A – No Cirrhosis
- Ombitasvir, Paritaprevir/Ritonavir Plus Dasabuvir Restricted To
- List of Selected Drugs
- New Hepatitis C Combination Agents
- Retreatment of Genotype 1 Hepatitis C Virus with Sofosbuvir, Simeprevir, and Ribavirin Following Treatment Failure with an NS5A
- Remdesivir from Wikipedia, the Free Encyclopedia
- ESAC-Net Reporting Protocol 2019.Docx
- Viekira Pak (Ombitasvir, Paritaprevir and Ritonavir Tablets Co-Packaged
- Hepatitis C – Viekira Pak™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets [Co-Packaged])
- Ombitasvir-Paritaprevir-Ritonavir (Technivie)
- Viekira Paktm)
- Dasabuvir, Ombitasvir, Paritaprevir, Ritonavir (Viekira Pak)
- Hepatitis C Sovaldi and Daklinza
- Step Therapy
- OMBITASVIR, PARITAPREVIR/RITONAVIR Co‐Formulated Tablet with Or Without DASABUVIR
- Descripción De Principios Activos
- 1. Patient Information 2. Insurance Information: 4. Physician
- Clinical Policy: Elbasvir/Grazoprevir (Zepatier) Reference Number: LA.PHAR.275 Effective Date: 09/16 Last Review Date: 05/18 Revision Log Line of Business: Medicaid
- Hepatitis C Medications Daklinza (Daclatasvir) Epclusa
- Viekira Pak Criteria
- Treatment of Hepatitis C Hepatitis C (HCV)
- ESAC-Net Reporting Protocol 2018.Docx Introduction
- Paritaprevir/Ombitasvir/Dasabuvir